These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 33189118)

  • 21. Clinical aspects of using exhaled NO in asthma diagnosis and management.
    Ludviksdottir D; Diamant Z; Alving K; Bjermer L; Malinovschi A
    Clin Respir J; 2012 Oct; 6(4):193-207. PubMed ID: 22898078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Review of the Utility and Cost Effectiveness of Monitoring Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management.
    Arnold RJ; Massanari M; Lee TA; Brooks E
    Manag Care; 2018 Jul; 27(7):34-41. PubMed ID: 29989900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Difficult-to-treat asthma in childhood.
    Adams A; Saglani S
    Paediatr Drugs; 2013 Jun; 15(3):171-9. PubMed ID: 23575982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe asthma: When to resort to biological agents.
    Tenero L; Rossignoli S; Piacentini G
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():37-39. PubMed ID: 32017206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of omalizumab in children from a middle-income country with severe therapy-resistant asthma: A real-life study.
    Pitrez PM; de Souza RG; Roncada C; Heinzmann-Filho JP; Santos G; Pinto LA; Jones MH; Stein RT
    Pediatr Pulmonol; 2017 Nov; 52(11):1408-1413. PubMed ID: 29027379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics of children and adolescents with severe therapy-resistant asthma in Brazil.
    Rodrigues AM; Roncada C; Santos G; Heinzmann-Filho JP; de Souza RG; Vargas MH; Pinto LA; Jones MH; Stein RT; Pitrez PM
    J Bras Pneumol; 2015; 41(4):343-50. PubMed ID: 26398754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RANTES in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy.
    Zietkowski Z; Skiepko R; Tomasiak-Lozowska MM; Lenczewska D; Bodzenta-Lukaszyk A
    Int Arch Allergy Immunol; 2011; 154(1):25-32. PubMed ID: 20664274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of exhaled nitric oxide measurements on treatment decisions in an asthma specialty clinic.
    LaForce C; Brooks E; Herje N; Dorinsky P; Rickard K
    Ann Allergy Asthma Immunol; 2014 Dec; 113(6):619-23. PubMed ID: 25060819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of asthma in school-aged children and adolescents.
    Durrani S
    Pediatr Ann; 2014 Aug; 43(8):e184-91. PubMed ID: 25102488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
    Petsky HL; Cates CJ; Li A; Kynaston JA; Turner C; Chang AB
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006340. PubMed ID: 19821360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving Asthma Outcomes: Strategies for the Future.
    Lim TK
    Ann Acad Med Singap; 2016 Dec; 45(12):532-533. PubMed ID: 28062880
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment.
    Magnan A; Bourdin A; Prazma CM; Albers FC; Price RG; Yancey SW; Ortega H
    Allergy; 2016 Sep; 71(9):1335-44. PubMed ID: 27087007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program.
    Cloutier MM; Dixon AE; Krishnan JA; Lemanske RF; Pace W; Schatz M
    JAMA; 2020 Dec; 324(22):2301-2317. PubMed ID: 33270095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung clearance index and steroid response in pediatric severe asthma.
    Irving S; Fleming L; Ahmad F; Biggart E; Bingham Y; Cook J; Hall P; Jamalzadeh A; Nagakumar P; Bossley C; Gupta A; Macleod K; Saglani S; Bush A
    Pediatr Pulmonol; 2020 Apr; 55(4):890-898. PubMed ID: 32027471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
    Katsaounou P; Buhl R; Brusselle G; Pfister P; Martínez R; Wahn U; Bousquet J
    Respir Med; 2019 Apr; 150():51-62. PubMed ID: 30961951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Latin-American Consensus on Difficult-to-Control Asthma. 2008 Update].
    Drugs Today (Barc); 2008 Jun; 44 Suppl 3():1-43. PubMed ID: 19093041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Workup of Severe Asthma.
    Couillard S; Jackson DJ; Wechsler ME; Pavord ID
    Chest; 2021 Dec; 160(6):2019-2029. PubMed ID: 34265308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologics for Severe Asthma: Treatment-Specific Effects Are Important in Choosing a Specific Agent.
    Krings JG; McGregor MC; Bacharier LB; Castro M
    J Allergy Clin Immunol Pract; 2019; 7(5):1379-1392. PubMed ID: 31076056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.
    Chung KF
    J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
    Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P
    Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.